Age of Presentation of Pulmonary Alveolar Proteinosis in Children with Lysinuric Protein Intolerance
Pulmonary alveolar proteinosis (PAP) in children with lysinuric protein intolerance (LPI) typically presents in infancy to early childhood, with cases documented as early as 8 months of age, though presentation can occur throughout childhood and even remain asymptomatic until later detection.
Clinical Presentation Timeline
The age of PAP presentation in LPI-affected children is highly variable:
Infancy: The earliest documented case involved an 8-month-old infant presenting with acute respiratory failure requiring ECMO support 1. This represents the severe, early-onset form associated with poor prognosis.
Early childhood: A 10-year-old patient died from severe respiratory insufficiency due to alveolar proteinosis, indicating that symptomatic disease can manifest in the first decade 2.
Asymptomatic detection: Critically, many children with LPI have PAP detected on imaging studies despite being completely asymptomatic 2. In one cohort, HRCT revealed lung involvement with acinar nodules, interstitial thickening, and subpleural cysts in asymptomatic patients, demonstrating that radiological disease precedes clinical symptoms.
Key Clinical Patterns
PAP is a constant feature in children with LPI who develop lung involvement 3. In a cohort of 14 LPI patients, 71% (10/14) developed lung involvement, and PAP was confirmed histopathologically in all cases 3.
The presentation pattern falls into three categories:
- Acute onset (5/10 patients): Rapid development of respiratory symptoms
- Progressive onset (3/10 patients): Gradual symptom development
- Asymptomatic (2/10 patients): Detected only on screening imaging
Critical Prognostic Consideration
Early-onset PAP in LPI is associated with severe disease and high mortality. In the pediatric cohort studied, 60% of patients with lung involvement died, all in the context of respiratory failure 3. The mortality occurred despite treatment attempts, underscoring the aggressive nature of early-onset disease.
Practical Screening Implications
Given that PAP can be asymptomatic yet progressive, HRCT is the most sensitive method for early diagnosis in LPI patients, even before clinical or functional impairment becomes evident 2. Conventional chest radiography and pulmonary function tests may be normal when HRCT already shows disease. Radioisotopic perfusion and ventilation studies also demonstrate abnormalities before functional impairment 2.
Important Caveats
- Presentation and course are highly variable, even within the same family 3
- Pulmonary fibrosis frequently coexists with PAP and may develop independently 3
- The heterogeneity means some patients remain asymptomatic while others present with life-threatening respiratory failure in infancy
- Regular surveillance imaging is warranted in all LPI patients regardless of symptoms, as early detection may influence management decisions before irreversible lung damage occurs